The aim of the proposed RCT is to assess the effectiveness of the ReHab-TOAT approach in improving arm function and arm skill performance in daily life tasks in chronic stroke patients with either a severely or moderately affected arm-hand (i.e.…
ID
Source
Brief title
Condition
- Central nervous system vascular disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary outcome measure for this RCT is the Brunnstrom-Fugl Meyer Test
(BFMT).
Secondary outcome
The secundary outcome measures for the patiens/participants are:
- Action research ARM Test (ARAT);
- Motor Activity Log (MAL);
- Accelerometry / gyroscopy;
- EuroQoL-5D.
In addition, the following questionnaires are administered to the persons from
the EXP group for the purpose of evaluating the technology used:
- System Usability Scale (SUS)
- Questionnaire on experience with the technology used.
All patient participants will also be asked a single question gauging the
occurrence of any event over the last 2 weeks that may influence the results of
the treatment or the measurements (e.g. the patient having had the flu in the
past 2 weeks).
Regarding the caregivers, the CarerQoL questionnaire will be administered.
Also a single question gauging the caregiver's amount of care provided to the
patient will be posed.
Background summary
One of the major deficits after a stroke is sensorimotor impairment in the
contralateral limb. A majority of these stroke patients has limited use of the
affected upper limb. One year after stroke, motor impairment of the upper limb
is associated with anxiety, lower perceived health-related quality of life and
a reduced subjective wel]-being. lmproving arm-hand skill performance is a
major therapeutic target in stroke rehabilitation. However, treatment time and
financial resources are limited. In order to solve these problems, new
technology is being used to assist training of patients. By using
technology-assisted training, arm function training and arm skill training may
be augmented both in amount and duration of training as well as in content
richness / variety and task specificity, thus providing optimal conditions for
challenging the patient's brain plasticity regarding sensorimotor
(re-)learning, yet, at the same time keep the workload for (para-)medical staff
and treatment costs manageable.
We developed a new task-oriented arm training approach using a so-called
'remote handling concept', to manipulate proprioception. This approach is
called "Remote Handling concept based, Task-Oriented Arm Training" (acronym:
ReHab-TOAT). We hypothesize that, given the brain's plasticity, proprioception
manipulation during task-oriented training may lead to improvements of arm
function and arm skill performance, and, ultimately improvement of quality of
life in persons in the chronic stage after a stroke. We also assume that, when
patients* arm function improves, they may need less (and less frequent) care
from caregivers, which may lead to a lower level of perceived burden and
improved quality of life in caregivers.
Study objective
The aim of the proposed RCT is to assess the effectiveness of the ReHab-TOAT
approach in improving arm function and arm skill performance in daily life
tasks in chronic stroke patients with either a severely or moderately affected
arm-hand (i.e. with an Utrechtse Arm test (UAT) score between 1-3). We also
want to gauge potential changes in patients* and caregivers* perceived quality
of life, and assess the patients* perception regarding the usability of the
technology used in ReHab-TOAT.
Study design
This randomized clinical trial features two arms (EXP and CONTR). The EXP group
will receive a 4 week ReHab-TOAT regime at a frequency of 3 sessions of 1.5
hours per week. This will be additional to any care the participants may
receive outside the research context. The EXP group will also receive 1
additional session to familiarize themselves with the training system, prior to
the start of the training phase. The CONTR group will not receive additional
arm-hand therapy apart from regular *maintenance* therapy, i.e. therapy
participants already may receive from therapists in their current home
situation (e.g. *1e-lijns* physiotherapy). For participants in both groups any
therapy they may potentially receive, will be inventoried and described. In our
protocol, no restrictions will be imposed on any (additional) therapies
participants currently receive.
The time and extent of care delivered to patients by their caregiver, as well
as quality of life of caregivers are also inventoried longitudinally.
Intervention
Participants in the EXP group receive ReHab-TOAT (Remote Handling Based
Task-Oriented Arm Training). ReHab-TOAT contains task-oriented arm training for
stroke patients in combination with haptic feedback, generated by a remote
handling device. They will train for 4 weeks, 3x per week, 1.5hr per day.
Participants in the CONTR group will receive no additional arm-hand therapy
apart from regular *maintenance* therapy, i.e. therapy they may already receive
from therapists in their current home situation (e.g. *1e-lijns*
physiotherapy).
Study burden and risks
The present RCT will investigate the effect of ReHab-TOAT, additionally to any
therapy as usual, on improving arm function and arm skill performance in
chronic stroke patients with a moderately to severely affected arm-hand
function, regarding daily upper extremity tasks. It is hypothesized that
provision of enriched proprioceptive information during arm-hand skill training
in chronic stroke patients may lead to higher levels of arm function and arm
skill performance than a) arm function and arm skill performance levels in the
CONTR group, and b) pre-treatment levels of arm function and arm skill
performance in subjects in the EXP condition. Furthermore, it is hypothesized
that these higher levels of arm function and arm skill performance in the EXP
group will be maintained across at least a period of 9 months
post-intervention, and will be higher during the follow-up period (of 9 months)
relative to arm function and arm skill performance levels in the CONTR group.
The patient may benefit from this RCT because we are able to train his/her arm
in a more functional way, thereby increasing the chance of reaching a higher
level of functional outcome, enabling him to perform his daily activities
better and improving the patient*s quality of life. We also think that reaching
a higher level of functional outcome may lead to the burden caregivers may
experience in providing care may decrease and their quality of life may
increase. There are already several technology-assisted arm-hand training
programs that have been evaluated in clinical trials. None of them reported any
side effects. In our own pilot study (CCMO code: NL70014.015.19), involving
ReHab-TOAT, no adverse events were observed. Furthermore, given the low net
forces that will be exerted by the DexterTM on the patient*s arm (i.e. in the
order of 0 N - 20 N) during arm activities also performed in daily life, as
well as the many safety features installed, the risks in the present study are
estimated to be low. Additionally, all measures used in the present RCT pose no
harm to the participant. They are also used as regular clinimetrics in
rehabilitation.
Zandbergsweg 111
Hoensbroek 6432CC
NL
Zandbergsweg 111
Hoensbroek 6432CC
NL
Listed location countries
Age
Inclusion criteria
Regarding patients:
- An unilateral stroke (ischemic or haemorrhagic) confirmed by brain imaging;
- Post-stroke time larger than 12 months;
- Hemiplegic pattern of arm motor impairment with UAT score 1-3;
- Age 18 years or older;
- Sufficient cognitive level, i.e. being able to understand the questionnaires
and measurement instructions.
Regarding patients' caregivers:
- Age 18 years or older;
- providing informal care to stroke patients from the group mentioned above.
Exclusion criteria
Regarding patients:
- Severe non-stroke related co-morbidity that may interfere with arm-hand
function;
- Additional complaints that may interfere with the execution of the
measurements;
- Spasticity in the affected upper limb, i.e. a Modified Ashworth Scale (MAS)
score >= 1+;
- Severe cognitive problems that prevent the patient from understanding the
tasks;
- No informed consent.
Regarding patients' caregivers:
- No informed consent.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
Other | Netherlands Trial Register: NL9541 |
CCMO | NL76382.015.21 |